Numaqula Omega-3 Interactions
There are 168 drugs known to interact with Numaqula Omega-3 (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 11 are major, 155 are moderate, and 2 are minor.
- View all 168 medications that may interact with Numaqula Omega-3
- View Numaqula Omega-3 alcohol/food interactions (1)
- View Numaqula Omega-3 disease interactions (7)
Most frequently checked interactions
View interaction reports for Numaqula Omega-3 (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Abilify (aripiprazole)
- acetaminophen
- Alcohol (contained in alcoholic beverages) (ethanol)
- alprazolam
- amlodipine
- atomoxetine
- bacillus coagulans / inulin
- Benadryl (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- bicalutamide
- bismuth subsalicylate
- cannabidiol
- cephalexin
- citalopram
- Claritin (loratadine)
- clindamycin
- Colace 2-in-1 (docusate/senna)
- dextromethorphan
- dextromethorphan / guaifenesin
- dicyclomine
- Eliquis (apixaban)
- estradiol
- famotidine
- Fiber Therapy (psyllium)
- Flonase (fluticasone nasal)
- Flonase Allergy Relief (fluticasone nasal)
- gabapentin
- omeprazole
- Vitamin D3 (cholecalciferol)
Numaqula Omega-3 alcohol/food interactions
There is 1 alcohol/food interaction with Numaqula Omega-3 (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin).
Numaqula Omega-3 disease interactions
There are 7 disease interactions with Numaqula Omega-3 (cholecalciferol / lutein / omega-3 polyunsaturated fatty acids / zeaxanthin) which include:
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- arrhythmias
- liver disease
- hepatobiliary dysfunction
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.